What Researchers Did
Researchers conducted a retrospective study on 22 patients with non-small cell lung cancer that had spread to multiple areas in the lungs, evaluating a treatment combining chemotherapy, regional hyperthermia, and hyperbaric oxygen therapy.
What They Found
The study reported that 14 (64%) of 22 patients showed an objective response to the treatment. Side effects were generally mild, with only one patient experiencing severe leucopenia/neutropenia and one patient experiencing severe pneumonitis. The median time until the disease progressed was 8 months for all patients, and 9 months for the 16 patients who received hyperbaric oxygen therapy.
What This Means for Canadian Patients
For Canadian patients with advanced non-small cell lung cancer that has spread to multiple areas in the lungs, this study suggests a combined approach of chemotherapy, hyperthermia, and hyperbaric oxygen therapy could be a promising treatment option. This multimodal strategy might offer a new avenue for managing a challenging form of lung cancer.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a retrospective case series with a small number of patients, this study's findings are preliminary and require confirmation through larger, controlled trials.